Repository logo
 

The influence of Dapagliflozin on dietary mediated physiological and behavioral changes

dc.contributor.authorRyan, Shane P. P., author
dc.contributor.authorBell, Christopher, advisor
dc.contributor.authorMelby, Christopher, committee member
dc.contributor.authorBraun, Barry, committee member
dc.date.accessioned2019-06-14T17:06:48Z
dc.date.available2021-06-10T17:05:25Z
dc.date.issued2019
dc.description.abstractThe diabetes medication, Dapagliflozin, is a sodium-glucose co-transporter 2 (SGLT2) inhibitor. The mechanism of action is decreasing renal absorption of glucose, leading to glucosuria, and modest weight loss. We hypothesized that SGLT2 inhibition would potentiate the favorable influence of dietary counseling on body composition and physiological adaptations in overweight or obese adults. Fifty sedentary overweight/obese men (n = 12) and women (n = 38) were randomly assigned to 12 weeks of dietary counseling for weight loss, supplemented with daily ingestion of either placebo or Dapagliflozin (up to 10 mg/day); coded as Pill A and Pill B. Dietary counseling consisted of weekly, one-on-one, 30-minute meetings targeting modest calorie restriction. Before and after treatment, body composition, resting metabolic rate (RMR), insulin sensitivity, appetite and satiety were measured. Twelve weeks of dietary counseling decreased (P < 0.049) body mass, fat mass, and RMR; neither variable was influenced by pill assignment (interaction: P > 0.264). Dietary counseling also decreased lean mass (treatment main effect: P < 0.001), however the decrease in lean mass was greater in Pill B than in Pill A (interaction: P = 0.037). Neither dietary counseling nor SGLT2 inhibition influenced insulin sensitivity (P > 0.055). Overall, 12-weeks of dietary counseling leads to favorable modification of body mass and fat mass regardless of pill assignment. However, Pill A appears to reduce the dietary counseling mediated loss in lean mass. Except for lean mass, the effects of dietary counseling for weight loss were not influenced by SGLT2 inhibition.
dc.format.mediumborn digital
dc.format.mediummasters theses
dc.identifierRyan_colostate_0053N_15443.pdf
dc.identifier.urihttps://hdl.handle.net/10217/195395
dc.languageEnglish
dc.language.isoeng
dc.publisherColorado State University. Libraries
dc.relation.ispartof2000-2019
dc.rightsCopyright and other restrictions may apply. User is responsible for compliance with all applicable laws. For information about copyright law, please see https://libguides.colostate.edu/copyright.
dc.titleThe influence of Dapagliflozin on dietary mediated physiological and behavioral changes
dc.typeText
dcterms.embargo.expires2021-06-10
dcterms.embargo.terms2021-06-10
dcterms.rights.dplaThis Item is protected by copyright and/or related rights (https://rightsstatements.org/vocab/InC/1.0/). You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s).
thesis.degree.disciplineHealth and Exercise Science
thesis.degree.grantorColorado State University
thesis.degree.levelMasters
thesis.degree.nameMaster of Science (M.S.)

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Ryan_colostate_0053N_15443.pdf
Size:
883.62 KB
Format:
Adobe Portable Document Format